SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015271
Filing Date
2020-08-11
Accepted
2020-08-11 17:00:14
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 470013
2 ex31-1.htm EX-31.1 12058
3 ex31-2.htm EX-31.2 11863
4 ex32-1.htm EX-32.1 4943
5 ex32-2.htm EX-32.2 5033
  Complete submission text file 0001493152-20-015271.txt   3170899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20200630.xml EX-101.INS 540389
7 XBRL SCHEMA FILE prph-20200630.xsd EX-101.SCH 52110
8 XBRL CALCULATION FILE prph-20200630_cal.xml EX-101.CAL 51514
9 XBRL DEFINITION FILE prph-20200630_def.xml EX-101.DEF 143029
10 XBRL LABEL FILE prph-20200630_lab.xml EX-101.LAB 317370
11 XBRL PRESENTATION FILE prph-20200630_pre.xml EX-101.PRE 213421
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 201093164
SIC: 2834 Pharmaceutical Preparations